GAD autoantibody epitope pattern after GAD-alum treatment in children and adolescents with type 1 diabetes
Pediatric Diabetes,

Skoglund C et al. – Glutamic acid decarboxylase formulated in alum (GAD–alum) injections did not affect binding of GADA to SPS–related epitopes, further supporting the safety of the treatment. There were no changes in GADA epitope specificity to the T1D–related epitopes, except for a temporarily increased binding to one of the tested epitopes.

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

    Currently, there are no available articles.

Your Unread Messages in Medical Student

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Medical Student Articles

Indexed Journals in Medical Student: Academic Medicine, BMC Medical Education, Medical Teachermore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close